(VIANEWS) - Methanex Corporation (MEOH), Afya (AFYA), ABIOMED (ABMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Methanex Corporation (MEOH)
23.1% sales growth and 18.82% return on equity
Methanex Corporation produces and supplies methanol in North America, the Asia Pacific, Europe, and South America.
Methanex Corporation's sales growth this year is expected to be 54.2% and a negative 11.6% for next year.
Year-on-year quarterly revenue growth grew by 85.5%, now sitting on 3.97B for the twelve trailing months.
Volume
Today's last reported volume for Methanex Corporation is 408959 which is 9.9% above its average volume of 372114.
Methanex Corporation's sales growth for the next quarter is 23.1%. The company's growth estimates for the current quarter and the next is 219.4% and 700%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.82%.
Volatility
Methanex Corporation's last day, last week, and last month's current volatility was 0.07%, 0.70%, and 1.96%, respectively.
Methanex Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.32% (day), 4.35% (last week), and 4.03% (last month), respectively.
Methanex Corporation's Stock Yearly Top and Bottom Value
Methanex Corporation's stock is valued at $44.78 at 11:22 EST, way below its 52-week high of $52.88 and way above its 52-week low of $28.86.
Methanex Corporation's Moving Average
Methanex Corporation's value is below its 50-day moving average of $46.31 and way higher than its 200-day moving average of $38.11.2. Afya (AFYA)
20.6% sales growth and 9.71% return on equity
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil.
Afya's sales growth this year is expected to be 30.7% and 24.9% for next year.
Year-on-year quarterly revenue growth grew by 35.8%, now sitting on 1.42B for the twelve trailing months.
Volume
Today's last reported volume for Afya is 14264 which is 87.37% below its average volume of 113009.
Afya's sales growth for the next quarter is 20.6%. The company's growth estimates for the present quarter and the next is 20% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.71%.
Volatility
Afya's last day, last week, and last month's current volatility was 0.72%, 2.35%, and 2.16%, respectively.
Afya's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.88% (day), 4.80% (last week), and 4.41% (last month), respectively.
Afya's Stock Yearly Top and Bottom Value
Afya's stock is valued at $16.26 at 11:22 EST, way under its 52-week high of $28.94 and higher than its 52-week low of $16.15.
Afya's Moving Average
Afya's worth is way under its 50-day moving average of $19.01 and way below its 200-day moving average of $22.38.3. ABIOMED (ABMD)
11.1% sales growth and 11.62% return on equity
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.
ABIOMED's sales growth this year is anticipated to be 20.4% and 15.9% for next year.
Year-on-year quarterly revenue growth grew by 18.3%, now sitting on 973.64M for the twelve trailing months.
Volume
Today's last reported volume for ABIOMED is 192817 which is 4.86% below its average volume of 202676.
ABIOMED's sales growth is a negative 0% for the present quarter and 11.1% for the next. The company's growth estimates for the current quarter and the next is a negative 28.1% and negative -9.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.62%.
Volatility
ABIOMED's last day, last week, and last month's current volatility was 1.41%, 2.52%, and 1.42%, respectively.
ABIOMED's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.45% (day), 4.40% (last week), and 3.13% (last month), respectively.
ABIOMED's Stock Yearly Top and Bottom Value
ABIOMED's stock is valued at $363.07 at 11:22 EST, under its 52-week high of $387.40 and way higher than its 52-week low of $254.41.
ABIOMED's Moving Average
ABIOMED's value is above its 50-day moving average of $343.19 and way above its 200-day moving average of $326.07.4. IPG Photonics Corporation (IPGP)
10% sales growth and 6.42% return on equity
IPG Photonics Corporation develops and manufactures a range of high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide.
IPG Photonics Corporation's sales growth this year is anticipated to be 20.7% and 11% for next year.
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 1.2B for the twelve trailing months.
Volume
Today's last reported volume for IPG Photonics Corporation is 235851 which is 30.66% below its average volume of 340178.
IPG Photonics Corporation's sales growth for the next quarter is 10%. The company's growth estimates for the present quarter and the next is 95.5% and 43.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.42%.
Volatility
IPG Photonics Corporation's last day, last week, and last month's current volatility was 0.01%, 0.89%, and 1.19%, respectively.
IPG Photonics Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.50% (day), 1.94% (last week), and 2.26% (last month), respectively.
IPG Photonics Corporation's Stock Yearly Top and Bottom Value
IPG Photonics Corporation's stock is valued at $159.00 at 11:22 EST, way below its 52-week high of $262.55 and above its 52-week low of $151.27.
IPG Photonics Corporation's Moving Average
IPG Photonics Corporation's value is under its 50-day moving average of $161.71 and way under its 200-day moving average of $189.53.5. Akamai Technologies (AKAM)
5.7% sales growth and 13.94% return on equity
Akamai Technologies, Inc. provides cloud services for delivering, optimizing, and securing content and business applications over the Internet in the United States and internationally.
Akamai Technologies's sales growth this year is expected to be 7.6% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 3.33B for the twelve trailing months.
Volume
Today's last reported volume for Akamai Technologies is 421500 which is 65.32% below its average volume of 1215530.
Akamai Technologies's sales growth for the next quarter is 5.7%. The company's growth estimates for the ongoing quarter and the next is 6.1% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.94%.
Volatility
Akamai Technologies's last day, last week, and last month's current volatility was 1.10%, 1.52%, and 0.98%, respectively.
Akamai Technologies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.17% (day), 2.64% (last week), and 1.79% (last month), respectively.
Akamai Technologies's Stock Yearly Top and Bottom Value
Akamai Technologies's stock is valued at $109.25 at 11:22 EST, way below its 52-week high of $124.91 and way higher than its 52-week low of $92.64.
Akamai Technologies's Moving Average
Akamai Technologies's worth is higher than its 50-day moving average of $106.33 and below its 200-day moving average of $112.28.6. Brixmor Property Group (BRX)
5.2% sales growth and 4.26% return on equity
Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers.
Brixmor Property Group's sales growth this year is anticipated to be 6.6% and 2.7% for next year.
Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 1.05B for the twelve trailing months.
Volume
Today's last reported volume for Brixmor Property Group is 2532090 which is 25.97% above its average volume of 2009930.
Brixmor Property Group's sales growth is a negative 0% for the current quarter and 5.2% for the next. The company's growth estimates for the ongoing quarter and the next is 66.7% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.26%.
Volatility
Brixmor Property Group's last day, last week, and last month's current volatility was 2.50%, 1.44%, and 1.28%, respectively.
Brixmor Property Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.85% (day), 2.52% (last week), and 2.21% (last month), respectively.
Brixmor Property Group's Stock Yearly Top and Bottom Value
Brixmor Property Group's stock is valued at $25.33 at 11:22 EST, below its 52-week high of $25.53 and way above its 52-week low of $11.08.
Brixmor Property Group's Moving Average
Brixmor Property Group's value is higher than its 50-day moving average of $23.29 and way higher than its 200-day moving average of $22.91.Previous days news about Brixmor Property Group(BRX)
- According to Benzinga on Monday, 1 November, "• Brixmor Property Group (NYSE:BRX) is estimated to report quarterly earnings at $0.10 per share on revenue of $278.81 million."